These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20597654)

  • 1. Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia.
    Bartlett JG; Barie PS; Niederman MS; Wunderink RG
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S1-3. PubMed ID: 20597654
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues in the design of clinical trials for antibacterial drugs for hospital-acquired pneumonia and ventilator‐associated pneumonia. Proceedings of a workshop co-sponsored by the US Food and Drug Administration, Infectious Diseases Society of America, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine. March 31-April 1 2009.
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S1-170. PubMed ID: 21058464
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective.
    Barriere SL
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S4-9. PubMed ID: 20597670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia.
    Kollef MH
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S29-35. PubMed ID: 20597668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for improving the design, conduct, and analysis of clinical trials in hospital-acquired pneumonia and ventilator-associated pneumonia.
    Powers JH
    Clin Infect Dis; 2010 Aug; 51 Suppl 1(Suppl 1):S18-28. PubMed ID: 20597667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
    ; ; ; ; Spellberg B; Talbot G
    Clin Infect Dis; 2010 Aug; 51 Suppl 1(Suppl 1):S150-70. PubMed ID: 20597666
    [No Abstract]   [Full Text] [Related]  

  • 7. Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design.
    Niederman MS
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S12-7. PubMed ID: 20597660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.
    Sorbello A; Komo S; Valappil T; Nambiar S
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S36-41. PubMed ID: 20597669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance in nosocomial respiratory infections.
    Denys GA; Relich RF
    Clin Lab Med; 2014 Jun; 34(2):257-70. PubMed ID: 24856527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: food and drug administration perspective.
    Laessig KA
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S117-9. PubMed ID: 20597659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing New Antibacterial Drug Development for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia.
    Toerner JG; Rubin D
    Clin Infect Dis; 2016 Aug; 63 Suppl 2():S37-8. PubMed ID: 27481951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
    File TM
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S42-7. PubMed ID: 20597671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumonia.
    Chastre J; Luyt CE
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S54-8. PubMed ID: 20597673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
    Jones RN
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S81-7. PubMed ID: 20597676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hospital-acquired pneumonia.
    Myrianthefs P; Ioannidis K; Baltopoulos G; Tsakris A
    Lancet Infect Dis; 2011 Oct; 11(10):729-30. PubMed ID: 21958577
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hospital-acquired pneumonia.
    Wolkewitz M; Cooper B; Barnett AG; Binder N; Schumacher M
    Lancet Infect Dis; 2011 Oct; 11(10):729; author reply 731-2. PubMed ID: 21958576
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hospital-acquired pneumonia.
    Bradley PJ
    Lancet Infect Dis; 2011 Oct; 11(10):730-1; author reply 731-2. PubMed ID: 21958578
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hospital-acquired pneumonia.
    Niederman MS; Craven DE; Chastre J; Kollef MH; Luna CM; Torres A; Wunderink RG
    Lancet Infect Dis; 2011 Oct; 11(10):728; author reply 731-2. PubMed ID: 21958575
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hospital-acquired pneumonia.
    Weng L; Hu X; Peng J; Wang J; Du B
    Lancet Infect Dis; 2011 Oct; 11(10):728-9; author reply 731-2. PubMed ID: 21958574
    [No Abstract]   [Full Text] [Related]  

  • 20. Shorter courses of antibiotic treatment for patients with pneumonia.
    Tanday S
    Lancet Respir Med; 2016 Sep; 4(9):691. PubMed ID: 27460162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.